ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

11 links0 made here, not in the record11 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07852195Testing the Use of HighDose Testosterone Followedby Darolutamide Compared tothe Usual Care for PatientsWith Metastatic ProstateCancerECOG-ACRIN Cancer Research GroPhase 2/Phase 3 · not yet recrRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Version of 2026-10-01CONDITIONSProstatic NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSAbiraterone AcetateIntervention entry›As of now · Rule based · ComparatorComparatorCabazitaxelIntervention entry›As of now · Rule based · ComparatorComparatorDarolutamideIntervention entry›As of now · Rule based · TestedTestedDexamethasoneIntervention entry›As of now · Rule based · ComparatorComparatorDocetaxelIntervention entry›As of now · Rule based · ComparatorComparatorEnzalutamideIntervention entry›As of now · Rule based · ComparatorComparatorLutetium (¹⁷⁷Lu) vipivotide…Entry “Lutetium Lu 177 Vipivotide Tet…›As of now · Rule based · ComparatorComparatorMethylprednisoloneIntervention entry›As of now · Rule based · ComparatorComparatorPrednisoneIntervention entry›As of now · Rule based · ComparatorComparatorTestosterone 17 beta-cypion…Entry “Testosterone Cypionate”, read …›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Prostatic Neoplasms

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryProstatic Neoplasms, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
As of nowProstatic NeoplasmsRule based · main-condition ruleMain conditionCurrent
As of nowAbiraterone AcetateRule based · role ruleComparatorCurrent
As of nowCabazitaxelRule based · role ruleComparatorCurrent
As of nowDarolutamideRule based · role ruleTestedCurrent
As of nowDexamethasoneRule based · role ruleComparatorCurrent
As of nowDocetaxelRule based · role ruleComparatorCurrent
As of nowEnzalutamideRule based · role ruleComparatorCurrent
As of nowLutetium (¹⁷⁷Lu) vipivotide tetraxetanRule based · role ruleComparatorCurrent
As of nowMethylprednisoloneRule based · role ruleComparatorCurrent
As of nowPrednisoneRule based · role ruleComparatorCurrent
As of nowTestosterone 17 beta-cypionateRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.